Loading…
SciSparc Ltd. is projected to decline to $6.96 by 2027, a -3% move from its current price of $7.16. SPRC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $6.47 | $7.16 | $7.92 | -0.03% |
| Aug 6 | $6.21 | $7.16 | $8.25 | -0.06% |
| Aug 7 | $6.01 | $7.15 | $8.52 | -0.09% |
| Aug 8 | $5.85 | $7.15 | $8.75 | -0.13% |
| Aug 9 | $5.71 | $7.15 | $8.95 | -0.16% |
| Aug 10 | $5.58 | $7.15 | $9.15 | -0.19% |
| Aug 11 | $5.47 | $7.14 | $9.33 | -0.22% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.47 | $7.14 | $9.33 | -0.22% |
| Week 2 | $4.89 | $7.13 | $10.39 | -0.44% |
| Week 3 | $4.48 | $7.11 | $11.29 | -0.66% |
| Week 4 | $4.16 | $7.10 | $12.09 | -0.87% |
| Week 5 | $3.90 | $7.08 | $12.85 | -1.09% |
| Week 6 | $3.68 | $7.07 | $13.57 | -1.31% |
| Week 7 | $3.48 | $7.05 | $14.27 | -1.52% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
SciSparc Ltd. is a clinical-stage pharmaceutical company that develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.
The company sells hemp seed oil-based products and others. It has an agreement with Procaps to develop and commercially manufacture SCI-110 and palmitoylethanolamide oral tablets CannAmide in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc.
The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.
SciSparc Ltd. (SPRC) is currently trading at $7.12 per share, with a market capitalization of $4.08M. Its market rank is 5329. The current price sits in a landscape shaped by technicals and a defined 30-day range. The 30-day range spans from $3.67 to $13.83, reflecting notable volatility over the period.
Key moving averages show SMA50 at $6.69 and SMA200 at $10.90, with a defined support at $4.27 and resistance at $9.09. These levels, together with the price, create a near-term technical frame for price exploration and potential test of resistance around the $9.09 level.
A major floor 72.0% below — a decisive break under it would weaken the trend.
The nearest floor, 40.4% below — buyers have tended to step in here.
The nearest ceiling, 27.0% above — a clean break opens room to run.
A major ceiling 62.7% above — clearing it would confirm fresh momentum.
Key SPRC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SPRC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.05 | Buy | $7.19 | Sell |
| MA 10 | $6.06 | Buy | $6.51 | Buy |
| MA 20 | $5.50 | Buy | $6.11 | Buy |
| MA 50 | $6.69 | Buy | $6.21 | Buy |
| MA 100 | $5.86 | Buy | $7.47 | Sell |
| MA 200 | $10.90 | Sell | $18.75 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.70 | Neutral |
| Stoch RSI (14) | 60.47 | Neutral |
| CCI (20) | 125.13 | Buy |
| Williams %R (14) | -40.87 | Info |
| MACD (12,26,9) | 0.44 | Buy |
| ROC (12) | 45.31 | Buy |
| Bollinger %B (20,2) | 0.82 | Neutral |
| Stochastic %K (14) | 59.13 | Neutral |
| TRIX (15) | -0.62 | Sell |
| Awesome (5,34) | 1.08 | Buy |
| Ultimate (7,14,28) | 62.31 | Neutral |
| Momentum (10) | 2.12 | Buy |
| Aroon Osc (25) | 44.00 | Buy |
| Hull MA (9) | 8.64 | Sell |
| ADX (14) | 18.36 | Neutral |
| ATR (14) | 0.69 | Info |
The 30-day technical picture leans bullish, with RSI14 at 60 indicating room for upside while not yet overbought. The current price of $7.12 sits above the SMA50 of $6.69, suggesting a near-term positive tilt, while the SMA200 at $10.90 implies longer-term resistance to a sustained advance.
Support is identified at $4.27 and resistance at $9.09, framing a near-term range that aligns with the 30-day low of $3.67 and high of $13.83. This mix of indicators points to a continued dynamic where upside attempts may test the $9.09 resistance, with downside risk limited by the $4.27 support.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.06 | $7.16 | $9.16 | 0% | Neutral | |
| $5.07 | $6.96 | $10.32 | -3% | Neutral | |
| $4.25 | $6.20 | $9.82 | -13% | Neutral | |
| $3.06 | $4.71 | $7.83 | -34% | Bearish | |
| $3.96 | $6.39 | $11.06 | -11% | Neutral | |
| $4.78 | $8.06 | $14.45 | +13% | Neutral | |
| $4.47 | $7.87 | $14.54 | +10% | Neutral | |
| $4.55 | $8.33 | $15.83 | +16% | Neutral | |
| $3.92 | $7.47 | $14.57 | +4% | Neutral | |
| $3.44 | $6.81 | $13.59 | -5% | Neutral | |
| $4.25 | $9.45 | $20.73 | +32% | Bullish | |
| $8.83 | $19.62 | $45.12 | +174% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $3.06 | $7.16 | $8.30 | +0.00% |
| September 2026 | $5.36 | $6.52 | $8.27 | -8.95% |
| October 2026 | $5.65 | $6.96 | $9.00 | +6.73% |
| November 2026 | $5.70 | $7.11 | $9.35 | +2.18% |
| December 2026 | $5.45 | $6.87 | $9.16 | -3.41% |
Click any year to see its month-by-month SPRC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect SPRC to range from $3.06 to $9.16 through 2026. The $7.16 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The SPRC price prediction for 2027 points to an average of $6.96 (low $5.07, high $10.32) — a potential decline of -3% on today's $7.16. Price action looks broadly range-bound.
In 2028, SPRC is projected to trade between $4.25 and $9.82, averaging $6.20 — a potential decline of -13% from today's $7.16. That is -11% versus the projected 2027 average. A consolidation phase looks the most probable path here.
SciSparc Ltd.'s 2029 outlook centres on $4.71, within a $3.06 to $7.83 range. That is -24% versus the projected 2028 average. That marks a -34% change versus current levels. A cyclical pullback looks likely — prices rarely move in a straight line.
By 2030, SPRC could reach as high as $11.06, with a base case around $6.39 and support toward $3.96 — roughly -11% from $7.16. A consolidation phase looks the most probable path here.
Expect SPRC to range from $4.78 to $14.45 through 2031. The $8.06 average target implies a +13% move from current prices. That is up +26% on the projected 2030 average. Price action looks broadly range-bound.
The SPRC price prediction for 2032 points to an average of $7.87 (low $4.47, high $14.54) — a potential gain of +10% on today's $7.16. A consolidation phase looks the most probable path here.
In 2033, SPRC is projected to trade between $4.55 and $15.83, averaging $8.33 — a potential gain of +16% from today's $7.16. That is up +6% on the projected 2032 average. Price action looks broadly range-bound.
SciSparc Ltd.'s 2034 outlook centres on $7.47, within a $3.92 to $14.57 range. That is -10% versus the projected 2033 average. That marks a +4% change versus current levels. A consolidation phase looks the most probable path here.
By 2035, SPRC could reach as high as $13.59, with a base case around $6.81 and support toward $3.44 — roughly -5% from $7.16. Price action looks broadly range-bound.
Expect SPRC to range from $4.25 to $20.73 through 2040. The $9.45 average target implies a +32% move from current prices. That is up +39% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The SPRC price prediction for 2050 points to an average of $19.62 (low $8.83, high $45.12) — a potential gain of +174% on today's $7.16. Momentum favours further upside here.
Investing $1,000 in SPRC today (≈ 139.664804 SPRC) could be worth
$2,740.14
+$1,740.14 (+174%) by 2050 · US Dollar
Based on the average projected SPRC price of $19.62 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SPRCwould be worth at today's price.
$1,000 invested in SPRC on Jul 31, 2025 (≈ 19.42502 SPRC) would be worth
$139.08
-$860.92 (-86.1%) today · 0.14× · US Dollar
Based on a SPRC entry price of $51.48 vs. today's $7.16.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.33 | $1,343.34 | +34.3% |
| 1 month ago | $5.15 | $1,390.29 | +39.0% |
| 3 months ago | $7.91 | $905.18 | -9.5% |
| 6 months ago | $6.93 | $1,033.19 | +3.3% |
| 1 year ago | $51.48 | $139.08 | -86.1% |
| All time (4.9y) ago | $22,113 | $0.32 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SPRC forecast.
Our base-case forecast reaches $14.00 around 2050.
Implied market cap at $14.00: $8.03M
The multi-year forecast shows a path with varied momentum across years. In 2026, the avg price is $7.12 with a min of $3.06 and a max of $9.11, and ROI of 0% (sentiment NEUTRAL). In 2027, the avg is $6.93, with a min of $5.05 and a max of $10.27 and ROI of -2.7% (NEUTRAL).
In 2028, the avg falls to $6.16 (min $4.22, max $9.75) with ROI -13.5% (NEUTRAL), and 2029 remains bearish with an avg of $4.68 (min $3.04, max $7.78) and ROI -34.3%. The trajectory improves afterward: 2030 avg $6.37 (min $3.95, max $11.03) with ROI -10.5% (NEUTRAL); 2031 avg $8.01 (min $4.75, max $14.36) with ROI 12.5% (NEUTRAL); 2032 avg $7.81 (min $4.44, max $14.44) with ROI 9.7% (NEUTRAL); 2033 avg $8.30 (min $4.53, max $15.79) with ROI 16.6% (NEUTRAL); 2034 avg $7.43 (min $3.90, max $14.47) with ROI 4.3% (NEUTRAL); 2035 avg $6.76 (min $3.41, max $13.48) with ROI -5.1% (NEUTRAL).
Longer term, 2040 shows a more favorable forecast with avg $9.37 (min $4.22, max $20.55) and ROI 31.6% (BULLISH). The most bullish read appears in 2050, with avg $19.52 (min $8.78, max $44.89) and ROI 174.1% (BULLISH). These figures illustrate potential upside into the 2040s and beyond, alongside periods of decline in earlier years.
Investors should treat these as estimates, not guarantees, and consider the associated volatility and risk.
Tap a question to reveal the answer.
Avg $6.37, min $3.95, max $11.03; roiPct -10.5%.
Forecasts are mixed. The 2026 avg is $7.12 with neutral sentiment and 0% ROI, but the path improves later with bullish outlook in 2040 (avg $9.37) and 2050 (avg $19.52), while some years such as 2029 show negative ROI. These are estimates, not guarantees.
According to the provided forecast, the max price by 2050 is $44.89, which means $50 is not projected in the given data.
Avg $6.93, min $5.05, max $10.27; roiPct -2.7%; sentiment NEUTRAL.
Current price is $7.12 and market cap is $4.08M.
SciSparc Ltd. Community Discussion
0Share your SciSparc Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.